All articles by Staff Writer
Staff Writer
Africa Health ExCon-2023: The Egyptian Authority for Unified Procurement (UPA) and the Arab Hospital Federation (AHF) signed a protocol on cooperation to consolidate the role of the Africa Health ExCon
The Egyptian Authority for Unified Procurement (UPA) and Arab Hospital Federation (AHF) on Tuesday signed a Protocol of Cooperation to enhance the role of the Africa Health ExCon-2023 in its second edition under the title ”Your gateway to Health and Innovation in Africa”. The Africa Health ExCon Exhibition is held under the patronage of His Excellency the Egyptian President Abdel Fattah El-Sisi. In addition, it will take place between the 7th and the 10th of June 2023 at the Egypt International Exhibition center in Cairo, Egypt.
Toronto Airport Authority Partners with Kraken Sense, a Leading Canadian Tech Company, as Part of Study to Combat COVID-19
TORONTO–(BUSINESS WIRE)–The Greater Toronto Airports Authority (GTAA) is partnering with Kraken Sense, a leader in real-time pathogen detection devices, as part of a study funded in part by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to conduct tests on airport wastewater for Monkeypox and Omicron, a variant of SARS-CoV-2, the virus that causes COVID-19. Kraken Sense is testing multiple samples of wastewater at Toronto Pearson Airport using their technology to obtain quantitative results in under an hour without sacrificing the accuracy of results in contrast to traditional PCR technology, which can take multiple days to turnaround.
Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia
LONDON–(BUSINESS WIRE)–Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, today announces that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for EP0042, a dual FLT-3 and Aurora kinase inhibitor.
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, Co-Founder, President and CEO will present at the SVB Securities Global Biopharma Conference.
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso
CARLSBAD, Calif.–(BUSINESS WIRE)– As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib). The CDx will help identify patients with non-small cell lung cancer (NSCLC) who may be eligible for treatment with Tagrisso by identifying tumors that exhibit epidermal growth factor receptor (EGFR) alterations including exon 21 L858R mutations, exon 19 deletions or T790M mutations.
Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries
RA’ANANA, Israel, Jan. 10, 2023 /PRNewswire/ — Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
HEIDELBERG, Germany – January 5, 2023 – Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content.
Kanazawa University research: Cancer biology: Some cancer cells can lose their capability to migrate
KANAZAWA, Japan, Jan. 17, 2023 /PRNewswire/ — In a study recently published in Cancer Science, researchers from Kanazawa University show how some intestinal cancer cells lose their ability to spread as they divide and can be eliminated as the cancer grows.
Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campus
HYDERABAD, India, Jan. 17, 2023 /PRNewswire/ — Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced the opening of a new High-Potency API (HPAPI) manufacturing facility at its cGMP API Manufacturing campus in Bidar, India. The addition of this new facility expands the company’s expertise across HPAPI development and manufacturing, providing its customers with a streamlined pathway for NCE development.